Ancora Advisors’s ZyVersa Therapeutics ZVSA Stock Holding History

Ancora Advisors’s Portfolio ZVSA Stock Details ZVSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-6	Closed	-$20K	–	1978
2022 Q3	$20K	Hold	6	–	–	﹤0.01%	1341
2022 Q2	$20K	Buy	+6	New	+$20.9K	﹤0.01%	1442

Other funds holding ZVSA

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

Ancora Advisors's ZVSA Position: Q4 2022 in Review

Ancora Advisors sold out of ZyVersa Therapeutics (ZVSA) in Q4 2022, closing a stake of 6 shares — an estimated $20K sold.

Ancora Advisors first reported a position in ZVSA in Q2 2022 and held it in 2 quarters. The position peaked at $20K in Q3 2022. 2 funds tracked by Wall St. Rank hold ZVSA as of Q4 2022.

Ancora Advisors reported no remaining ZyVersa Therapeutics position as of Q4 2022 after selling out during the quarter.
Ancora Advisors sold 6 ZyVersa Therapeutics shares in Q4 2022, an estimated $20K.
Ancora Advisors first reported a position in ZyVersa Therapeutics in Q2 2022 and held it in 2 quarters.
Ancora Advisors's ZyVersa Therapeutics position peaked at $20K in Q3 2022.
2 funds tracked by Wall St. Rank held ZyVersa Therapeutics as of Q4 2022.

Based on Ancora Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.